Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting
The most significant obstacle in the treatment of neurological disorders is the blood-brain barrier (BBB), which prevents 98% of all potential neuropharmaceuticals from reaching the central nervous system (CNS). Brain derived neurotrophic factor (BDNF) is one of the most intensely studied targets in...
Saved in:
Main Authors: | Grishma Pawar (Author), Neha N. Parayath (Author), Aditya A. Sharma (Author), Carlos Coito (Author), Olga Khorkova (Author), Jane Hsiao (Author), William T. Curry (Author), Mansoor M. Amiji (Author), Benjamin S. Bleier (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcome Comparison of Endoscopic (Endonasal Trans-Sphenoidal) Repairs of CSF Leak vs. Transcranial Approach
by: Mehran Ali, et al.
Published: (2022) -
How I do it : Endoscopic Endonasal Surgery for Craniopharyngioma
by: Suresh Sankhla, et al.
Published: (2022) -
Preventing acute neurotoxicity of CNS therapeutic oligonucleotides with the addition of Ca2+ and Mg2+ in the formulation
by: Rachael Miller, et al.
Published: (2024) -
l-Type amino acid transporter 1-targeting nanoparticles for antisense oligonucleotide delivery to the CNS
by: Yu Na Lim, et al.
Published: (2024) -
Plerixafor - Does it affect engraftment kinetics?
by: Satyendra Batra, et al.
Published: (2024)